Abstract
Background: Sterols are the main components of fungal membranes. Inhibiting their biosynthesis is the mode of action of azole antifungal drugs that are widely used to treat fungal disease including aspergillosis. Azole resistance has emerged as a matter of concern but little is known about sterols biosynthesis in azole resistant Aspergillus fumigatus. Methods: We explored the sterol composition of 12 A. fumigatus isolates, including nine azole resistant isolates with TR34/L98H, TR46/Y121F/T289A or TR53 alterations in the cyp51A gene and its promoter conferring azole resistance. Modifications in sterol composition were also investigated after exposure to two azole drugs, itraconazole and voriconazole. Results: Overall, under basal conditions, sterol compositions were qualitatively equivalent, whatever the alterations in the target of azole drugs with ergosterol as the main sterol detected. Azole exposure reduced ergosterol composition and the qualitative composition of sterols was similar in both susceptible and resistant isolates. Interestingly TR53 strains behaved differently than other strains. Conclusions: Elucidating sterol composition in azole-susceptible and resistant isolates is of interest for a better understanding of the mechanism of action of these drugs and the mechanism of resistance of fungi.
Highlights
Two ergosterol isomers were identified but ergosterol Z has never been described in previous fungal sterol analysis
We described for the first-time relative sterol composition of azoleresistant Aspergillus isolates with complex alterations in the cyp51A gene and/or its promotor, which are linked to environmental exposition to azole fungicides
This study highlights that TR34 /L98H and TR46 /Y121F/T289A alterations had no impact on relative composition of sterols in basal conditions when compared with susceptible isolates
Summary
Azole-drugs (itraconazole, voriconazole, posaconazole and isavuconazole) are the first-line therapy for prevention and treatment of Aspergillus infections [1,2]. They act by inhibiting the 14α-lanosterol demethylase, which has a key role in ergosterol biosynthesis [3]. Sterols are the main components of fungal membranes Inhibiting their biosynthesis is the mode of action of azole antifungal drugs that are widely used to treat fungal disease including aspergillosis. Conclusions: Elucidating sterol composition in azole-susceptible and resistant isolates is of interest for a better understanding of the mechanism of action of these drugs and the mechanism of resistance of fungi
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
